Biomimetic nanotherapy shows promise for treating fatal lung scarring disease
Chinese scientists have developed a novel nanotherapy known as biomimetic extracellular vesicle spherical nucleic acids (BEV-SNAs), which has shown efficacy in treating idiopathic pulmonary fibrosis (IPF). The study was published in the journal Aggregate.
Chinese scientists have developed a novel nanotherapy known as biomimetic extracellular vesicle spherical nucleic acids (BEV-SNAs), which has shown efficacy in treating idiopathic pulmonary fibrosis (IPF). The study was published in the journal Aggregate.
